BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36868448)

  • 41. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal co-exposure to mercury and perfluoroalkyl acid isomers and their associations with child neurodevelopment in a Canadian birth cohort.
    Reardon AJF; Hajihosseini M; Dinu I; Field CJ; Kinniburgh DW; MacDonald AM; Dewey D; England-Mason G; Martin JW;
    Environ Int; 2023 Aug; 178():108087. PubMed ID: 37454627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - A nested case-control study.
    Schillemans T; Shi L; Donat-Vargas C; Hanhineva K; Tornevi A; Johansson I; Koponen J; Kiviranta H; Rolandsson O; Bergdahl IA; Landberg R; Åkesson A; Brunius C
    Environ Int; 2021 Jan; 146():106180. PubMed ID: 33113464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Per- and perfluoroalkyl substances alternatives, mixtures and liver function in adults: A community-based population study in China.
    Liu JJ; Cui XX; Tan YW; Dong PX; Ou YQ; Li QQ; Chu C; Wu LY; Liang LX; Qin SJ; Zeeshan M; Zhou Y; Hu LW; Liu RQ; Zeng XW; Dong GH; Zhao XM
    Environ Int; 2022 May; 163():107179. PubMed ID: 35325771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?
    Hu XC; Dassuncao C; Zhang X; Grandjean P; Weihe P; Webster GM; Nielsen F; Sunderland EM
    Environ Health; 2018 Feb; 17(1):11. PubMed ID: 29391068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure-A study in Ronneby, Sweden.
    Li Y; Andersson A; Xu Y; Pineda D; Nilsson CA; Lindh CH; Jakobsson K; Fletcher T
    Environ Int; 2022 May; 163():107198. PubMed ID: 35447437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gestational exposure to perfluoroalkyl substances and congenital heart defects: A nested case-control pilot study.
    Ou Y; Zeng X; Lin S; Bloom MS; Han F; Xiao X; Wang H; Matala R; Li X; Qu Y; Nie Z; Dong G; Liu X
    Environ Int; 2021 Sep; 154():106567. PubMed ID: 33882431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.
    Sun Q; Zong G; Valvi D; Nielsen F; Coull B; Grandjean P
    Environ Health Perspect; 2018 Mar; 126(3):037001. PubMed ID: 29498927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment.
    Spratlen MJ; Perera FP; Lederman SA; Rauh VA; Robinson M; Kannan K; Trasande L; Herbstman J
    Environ Pollut; 2020 Aug; 263(Pt B):114444. PubMed ID: 32272335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of prenatal PFAS exposure and early childhood neurodevelopment: Evidence from the Shanghai Maternal-Child Pairs Cohort.
    Zhou Y; Li Q; Wang P; Li J; Zhao W; Zhang L; Wang H; Cheng Y; Shi H; Li J; Zhang Y
    Environ Int; 2023 Mar; 173():107850. PubMed ID: 36857906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
    Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
    Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal perfluorooctanoic acid exposure is associated with early onset atopic dermatitis in 5-year-old children.
    Wen HJ; Wang SL; Chuang YC; Chen PC; Guo YL
    Chemosphere; 2019 Sep; 231():25-31. PubMed ID: 31128349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
    Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
    Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
    Wen X; Wang M; Xu X; Li T
    Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.
    Foguth RM; Flynn RW; de Perre C; Iacchetta M; Lee LS; Sepúlveda MS; Cannon JR
    Toxicol Appl Pharmacol; 2019 Aug; 377():114623. PubMed ID: 31195004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.